A research team at POSTECH led by Professor Wook-Shin Han of the Department of Computer Science and Engineering and the ...

Anthropic has warned that recursive-self-improving AI could be on the horizon, but the truth is the company is more ...

Dr. Pramod Varma joins host Tushar Shetty to discuss the design philosophy and the next stages of India’s Digital Public ...

In this article, author Aaditya Chauhan discusses the limitations of RAG pipelines based purely on vector search and how an ...

Huawei has launched a new full-stack data infrastructure offering for AI data centers. Revealed during Huawei's Innovative Data Infrastructure Forum 2026, the launch includes the OceanStor Pacific ...

Members of the Danville-Pittsylvania Regional Industrial Facility Authority unanimously approved a local performance agreement Monday with Denver-based data center developer and operator Stack ...

Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

May 6 (Reuters) - Stack Infrastructure, a data centre firm owned by Blue Owl Capital, is considering its options, including a sale of its Asia operations in a deal valued at more ‌than $30 billion, ...

David Pogue is a six-time Emmy winner for his stories on "CBS Sunday Morning," where he's been a correspondent since 2002. Pogue hosts the CBS News podcast "Unsung Science." He's also a New York Times ...

CINCINNATI—Late at night, or when her 18-month-old daughter is napping, Jessica Sharp logs onto Chat GPT and asks it to help her in her fight to stop a data center from being built just steps away ...

I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be Recursion (RXRX). The reason why I want to go over this biotech next is because the company ...